Dalla medicina reattiva alla medicina di precisione

In recent years, there has been increased awareness of a concept of medicine based on individual differences taking into consideration genetic variability, environment, characteristics of the microbiome and individual lifestyles. It makes use of genomics, transcriptomics, proteomics and metabolomics...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra La Rosa (Author), Chiara Guglielmo (Author), Alessandra Ocello (Author), Concetto Sessa (Author), Giuseppe Seminara (Author), Antonio Granata (Author)
Format: Book
Published: AboutScience Srl, 2021-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6eafb0d3d474426cb1342fdce509c662
042 |a dc 
100 1 0 |a Sandra La Rosa  |e author 
700 1 0 |a Chiara Guglielmo  |e author 
700 1 0 |a Alessandra Ocello  |e author 
700 1 0 |a Concetto Sessa  |e author 
700 1 0 |a Giuseppe Seminara  |e author 
700 1 0 |a Antonio Granata  |e author 
245 0 0 |a Dalla medicina reattiva alla medicina di precisione 
260 |b AboutScience Srl,   |c 2021-09-01T00:00:00Z. 
500 |a 10.33393/gcnd.2021.2316 
500 |a 2705-0076 
520 |a In recent years, there has been increased awareness of a concept of medicine based on individual differences taking into consideration genetic variability, environment, characteristics of the microbiome and individual lifestyles. It makes use of genomics, transcriptomics, proteomics and metabolomics techniques, obtaining a large amount of information which enables a more precise characterization of the patient. This model expands to the principles of prediction, prevention, personalization and participation, including all medical specialties. In nephrology, the application of precision medicine could play a central role, thanks to the information available today in multiple fields: for example the impact of alterations in the intestinal microbiota on the progression of chronic renal failure, in polycystic disease, in diabetic nephropathy and in the personalized approach to the transition period before the beginning of hemodialysis therapy. 
546 |a IT 
690 |a Genomics 
690 |a Patient characterization 
690 |a Personalized medicine 
690 |a Precision medicine 
690 |a Transcriptomics 
690 |a Internal medicine 
690 |a RC31-1245 
690 |a Diseases of the genitourinary system. Urology 
690 |a RC870-923 
655 7 |a article  |2 local 
786 0 |n Giornale di Clinica Nefrologia e Dialisi, Vol 33 (2021) 
787 0 |n https://journals.aboutscience.eu/index.php/gcnd/article/view/2316 
787 0 |n https://doaj.org/toc/2705-0076 
856 4 1 |u https://doaj.org/article/6eafb0d3d474426cb1342fdce509c662  |z Connect to this object online.